{"id":24521,"date":"2022-07-25T17:20:46","date_gmt":"2022-07-25T11:50:46","guid":{"rendered":"https:\/\/www.fundsindia.com\/blog\/?p=24521"},"modified":"2022-07-25T17:26:43","modified_gmt":"2022-07-25T11:56:43","slug":"alpha-eris-lifesciences-ltd-equity-research-desk","status":"publish","type":"post","link":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521","title":{"rendered":"Alpha | Eris Lifesciences Ltd. &#8211; Equity Research Desk"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/FI_Alpha-ErisLifeSciencesLtd.pdf\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" width=\"983\" height=\"467\" src=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png\" alt=\"\" class=\"wp-image-24522\" srcset=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png 983w, https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1-300x143.png 300w, https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1-768x365.png 768w\" sizes=\"(max-width: 983px) 100vw, 983px\" \/><\/a><\/figure>\n\n\n\n<h2><strong>Eris Lifesciences Ltd \u2013 Therapeutic returns<\/strong><\/h2>\n\n\n\n<p>Eris was incorporated as a public company in February 2007. It is engaged in manufacturing and marketing branded finished dosages in the Indian Pharmaceutical Market since 2007. <\/p>\n\n\n\n<p>It has a presence in the high-growth chronic and acute therapeutic areas that require the high intervention of specialists and super specialists. <\/p>\n\n\n\n<p>Its diverse product portfolio comprises 80+ mother brand groups that are focused primarily on lifestyle-related disorders. The company has drugs for Anti-Diabetes, Cardiovascular, Gastroenterology and Gynecology, Anti-Infectives, Vitamins, and other therapeutic areas. <\/p>\n\n\n\n<h2><strong>Valuation:<\/strong><\/h2>\n\n\n\n<p>We believe Eris\u2019 focus on lifestyle-related disease therapies will continue to drive growth in its chronic category. In the last ten years, Eris clocked a steady revenue and PAT CAGR growth of 17\/27%. We believe the margin should remain around 35-36% over the next few years, the highest among all domestic formulation companies. We recommend an ACCUMULATE rating on the stock with a revised Target price (TP) of Rs.800, 22x FY24E EPS.\u00a0<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/FI_Alpha-ErisLifeSciencesLtd.pdf\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" width=\"534\" height=\"66\" src=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2022\/06\/button_click-here-for-the-research-report.png\" alt=\"\" class=\"wp-image-23892\" srcset=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/06\/button_click-here-for-the-research-report.png 534w, https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/06\/button_click-here-for-the-research-report-300x37.png 300w\" sizes=\"(max-width: 534px) 100vw, 534px\" \/><\/a><\/figure><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Eris Lifesciences Ltd \u2013 Therapeutic returns Eris was incorporated as a public company in February 2007. It is engaged in manufacturing and marketing branded finished dosages in the Indian Pharmaceutical Market since 2007. It has a presence in the high-growth chronic and acute therapeutic areas that require the high intervention of specialists and super specialists. [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":24522,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[743,59],"tags":[744,200,746,781,517,745,272],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Alpha | Eris Lifesciences Ltd. - Equity Research Desk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alpha | Eris Lifesciences Ltd. - Equity Research Desk\" \/>\n<meta property=\"og:description\" content=\"Eris Lifesciences Ltd \u2013 Therapeutic returns Eris was incorporated as a public company in February 2007. It is engaged in manufacturing and marketing branded finished dosages in the Indian Pharmaceutical Market since 2007. It has a presence in the high-growth chronic and acute therapeutic areas that require the high intervention of specialists and super specialists. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521\" \/>\n<meta property=\"og:site_name\" content=\"Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fundsindia\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-25T11:50:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-25T11:56:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"983\" \/>\n\t<meta property=\"og:image:height\" content=\"467\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Equities Desk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\",\"name\":\"Wealth India Financial Services\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/fundsindia\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"width\":189,\"height\":200,\"caption\":\"Wealth India Financial Services\"},\"image\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"name\":\"Insights\",\"description\":\"Official blog of FundsIndia.com\",\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png\",\"contentUrl\":\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png\",\"width\":983,\"height\":467},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage\",\"url\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521\",\"name\":\"Alpha | Eris Lifesciences Ltd. - Equity Research Desk\",\"isPartOf\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage\"},\"datePublished\":\"2022-07-25T11:50:46+00:00\",\"dateModified\":\"2022-07-25T11:56:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fundsindia.com\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpha | Eris Lifesciences Ltd. &#8211; Equity Research Desk\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#article\",\"isPartOf\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage\"},\"author\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\"},\"headline\":\"Alpha | Eris Lifesciences Ltd. &#8211; Equity Research Desk\",\"datePublished\":\"2022-07-25T11:50:46+00:00\",\"dateModified\":\"2022-07-25T11:56:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage\"},\"wordCount\":164,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png\",\"keywords\":[\"Alpha\",\"equities\",\"Equity Research\",\"Eris Lifesciences Ltd.\",\"FundsIndia\",\"FundsIndia Equity Research\",\"stocks\"],\"articleSection\":[\"Alpha\",\"Equity Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\",\"name\":\"Equities Desk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"caption\":\"Equities Desk\"},\"sameAs\":[\"http:\/\/www.fundsindia.com\"],\"url\":\"https:\/\/fundsindia.com\/blog\/author\/equities-desk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alpha | Eris Lifesciences Ltd. - Equity Research Desk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521","og_locale":"en_US","og_type":"article","og_title":"Alpha | Eris Lifesciences Ltd. - Equity Research Desk","og_description":"Eris Lifesciences Ltd \u2013 Therapeutic returns Eris was incorporated as a public company in February 2007. It is engaged in manufacturing and marketing branded finished dosages in the Indian Pharmaceutical Market since 2007. It has a presence in the high-growth chronic and acute therapeutic areas that require the high intervention of specialists and super specialists. [&hellip;]","og_url":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521","og_site_name":"Insights","article_publisher":"https:\/\/www.facebook.com\/fundsindia","article_published_time":"2022-07-25T11:50:46+00:00","article_modified_time":"2022-07-25T11:56:43+00:00","og_image":[{"width":983,"height":467,"url":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png","type":"image\/png"}],"twitter_misc":{"Written by":"Equities Desk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.fundsindia.com\/blog\/#organization","name":"Wealth India Financial Services","url":"https:\/\/www.fundsindia.com\/blog\/","sameAs":["https:\/\/www.facebook.com\/fundsindia"],"logo":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#logo","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","width":189,"height":200,"caption":"Wealth India Financial Services"},"image":{"@id":"https:\/\/www.fundsindia.com\/blog\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.fundsindia.com\/blog\/#website","url":"https:\/\/www.fundsindia.com\/blog\/","name":"Insights","description":"Official blog of FundsIndia.com","publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage","inLanguage":"en-US","url":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png","contentUrl":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png","width":983,"height":467},{"@type":"WebPage","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage","url":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521","name":"Alpha | Eris Lifesciences Ltd. - Equity Research Desk","isPartOf":{"@id":"https:\/\/www.fundsindia.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage"},"datePublished":"2022-07-25T11:50:46+00:00","dateModified":"2022-07-25T11:56:43+00:00","breadcrumb":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fundsindia.com\/blog"},{"@type":"ListItem","position":2,"name":"Alpha | Eris Lifesciences Ltd. &#8211; Equity Research Desk"}]},{"@type":"Article","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#article","isPartOf":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage"},"author":{"@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656"},"headline":"Alpha | Eris Lifesciences Ltd. &#8211; Equity Research Desk","datePublished":"2022-07-25T11:50:46+00:00","dateModified":"2022-07-25T11:56:43+00:00","mainEntityOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#webpage"},"wordCount":164,"commentCount":0,"publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"image":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#primaryimage"},"thumbnailUrl":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png","keywords":["Alpha","equities","Equity Research","Eris Lifesciences Ltd.","FundsIndia","FundsIndia Equity Research","stocks"],"articleSection":["Alpha","Equity Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fundsindia.com\/blog\/equities\/alpha-eris-lifesciences-ltd-equity-research-desk\/24521#respond"]}]},{"@type":"Person","@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656","name":"Equities Desk","image":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","caption":"Equities Desk"},"sameAs":["http:\/\/www.fundsindia.com"],"url":"https:\/\/fundsindia.com\/blog\/author\/equities-desk"}]}},"jetpack_featured_media_url":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2022\/07\/Alpha-New-1-1.png","_links":{"self":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/24521"}],"collection":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/comments?post=24521"}],"version-history":[{"count":1,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/24521\/revisions"}],"predecessor-version":[{"id":24524,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/24521\/revisions\/24524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/media\/24522"}],"wp:attachment":[{"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/media?parent=24521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/categories?post=24521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fundsindia.com\/blog\/wp-json\/wp\/v2\/tags?post=24521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}